244 related articles for article (PubMed ID: 23297816)
1. Low incidence of hepatitis C virus among prisoners in Scotland.
Taylor A; Munro A; Allen E; Dunleavy K; Cameron S; Miller L; Hickman M
Addiction; 2013 Jul; 108(7):1296-304. PubMed ID: 23297816
[TBL] [Abstract][Full Text] [Related]
2. Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland.
Stone J; Martin NK; Hickman M; Hutchinson SJ; Aspinall E; Taylor A; Munro A; Dunleavy K; Peters E; Bramley P; Hayes PC; Goldberg DJ; Vickerman P
Addiction; 2017 Jul; 112(7):1302-1314. PubMed ID: 28257600
[TBL] [Abstract][Full Text] [Related]
3. Incidence, prevalence and risk factors for hepatitis C in Danish prisons.
Søholm J; Holm DK; Mössner B; Madsen LW; Hansen JF; Weis N; Sauer AP; Awad T; Christensen PB
PLoS One; 2019; 14(7):e0220297. PubMed ID: 31348813
[TBL] [Abstract][Full Text] [Related]
4. The seroprevalence of untreated chronic hepatitis C virus (HCV) infection and associated risk factors in male Irish prisoners: a cross-sectional study, 2017.
Crowley D; Lambert JS; Betts-Symonds G; Cullen W; Keevans M; Kelly E; Laird E; McHugh T; McKiernan S; Miggin SJ; Murphy C; Murtagh R; O'Reilly D; Tobin C; Van Hout MC
Euro Surveill; 2019 Apr; 24(14):. PubMed ID: 30968825
[TBL] [Abstract][Full Text] [Related]
5. Incidence and correlates of hepatitis C virus infection in a large cohort of prisoners who have injected drugs.
Snow KJ; Young JT; Preen DB; Lennox NG; Kinner SA
BMC Public Health; 2014 Aug; 14():830. PubMed ID: 25113132
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.
Belaunzarán-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Sierra-Madero JG; Ahmed S; Beyrer C
PLoS One; 2017; 12(6):e0179931. PubMed ID: 28654650
[TBL] [Abstract][Full Text] [Related]
7. Modelling the impact of a national scale-up of interventions on hepatitis C virus transmission among people who inject drugs in Scotland.
Fraser H; Mukandavire C; Martin NK; Goldberg D; Palmateer N; Munro A; Taylor A; Hickman M; Hutchinson S; Vickerman P
Addiction; 2018 Nov; 113(11):2118-2131. PubMed ID: 29781207
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment and prevention strategies for hepatitis C virus elimination in the prisons in New South Wales: a modelling study.
Bretaña NA; Gray RR; Cunningham EB; Betz-Stablein B; Ribeiro R; Graw F; Luciani F; Lloyd AR
Addiction; 2020 May; 115(5):901-913. PubMed ID: 31633853
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
Miller ER; Bi P; Ryan P
Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
[TBL] [Abstract][Full Text] [Related]
10. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
[TBL] [Abstract][Full Text] [Related]
11. Tattooing in prisons--not such a pretty picture.
Hellard ME; Aitken CK; Hocking JS
Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
[TBL] [Abstract][Full Text] [Related]
12. Association between universal hepatitis B prison vaccination, vaccine uptake and hepatitis B infection among people who inject drugs.
Palmateer NE; Goldberg DJ; Munro A; Taylor A; Yeung A; Wallace LA; Mitchell A; Shepherd SJ; Gunson RN; Aitken C; Hutchinson SJ
Addiction; 2018 Jan; 113(1):80-90. PubMed ID: 28710874
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of hepatitis C incidence in Australian prisoners.
Luciani F; Bretaña NA; Teutsch S; Amin J; Topp L; Dore GJ; Maher L; Dolan K; Lloyd AR;
Addiction; 2014 Oct; 109(10):1695-706. PubMed ID: 24916002
[TBL] [Abstract][Full Text] [Related]
14. Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland.
Allen EJ; Palmateer NE; Hutchinson SJ; Cameron S; Goldberg DJ; Taylor A
Int J Drug Policy; 2012 Sep; 23(5):346-52. PubMed ID: 22940142
[TBL] [Abstract][Full Text] [Related]
15. Tattooing in prison: a risk factor for HCV infection among inmates in the Quebec's provincial correctional system.
Poulin C; Courtemanche Y; Serhir B; Alary M
Ann Epidemiol; 2018 Apr; 28(4):231-235. PubMed ID: 29576049
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C antibody prevalence among Mexico City prisoners injecting legal and illegal substances.
Silverman-Retana O; Serván-Mori E; McCoy SI; Larney S; Bautista-Arredondo S
Drug Alcohol Depend; 2017 Dec; 181():140-145. PubMed ID: 29054033
[TBL] [Abstract][Full Text] [Related]
17. Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting.
Lafferty L; Rance J; Treloar C
Drug Alcohol Depend; 2018 Feb; 183():96-101. PubMed ID: 29245104
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of and risk factors for HCV among incarcerated people at Great Tehran Prison: a cross-sectional study.
SeyedAlinaghi S; Farhoudi B; Shahmohamadi E; Rasoolinejad M; Hasannezhad M; Rashidi MR; Dadras O; Moradi A; Parmoon Z; Ebrahimi H; Asadollahi-Amin A
Int J Prison Health; 2023 Feb; ():. PubMed ID: 36757302
[TBL] [Abstract][Full Text] [Related]
19. Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions.
Palmateer NE; Taylor A; Goldberg DJ; Munro A; Aitken C; Shepherd SJ; McAllister G; Gunson R; Hutchinson SJ
PLoS One; 2014; 9(8):e104515. PubMed ID: 25110927
[TBL] [Abstract][Full Text] [Related]
20. Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries.
Bielen R; Stumo SR; Halford R; Werling K; Reic T; Stöver H; Robaeys G; Lazarus JV
Harm Reduct J; 2018 May; 15(1):25. PubMed ID: 29751763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
